TSURUHA Raises Earnings Outlook and Sets Dividend Post-WELCIA Integration

TSURUHA Holdings ( (JP:3391) ) just unveiled an update.

TSURUHA Holdings has issued its first full-year consolidated earnings forecast for the fiscal year ending February 28, 2026, reflecting the impact of its December 2025 business integration with WELCIA Holdings. The company now projects net sales of ¥1.453 trillion, operating income of ¥63.3 billion and net income attributable to owners of the parent of ¥39.5 billion, with profitability boosted by goodwill-related accounting from the consolidation of WELCIA and a gain on step acquisition, alongside incorporation of WELCIA’s fourth-quarter results and a reassessment of TSURUHA’s own fourth quarter. In tandem, TSURUHA revised its year-end dividend forecast to ¥23 per share on a post–stock split basis (equivalent to ¥115 without the split), calibrating total year-end payouts so that the combined dividends from TSURUHA and WELCIA are on par with interim distributions, and announced plans to enhance shareholder benefit programs as it refines its shareholder return policy under the new group structure.

The most recent analyst rating on (JP:3391) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on TSURUHA Holdings stock, see the JP:3391 Stock Forecast page.

More about TSURUHA Holdings

TSURUHA Holdings is a major Japanese operator of drugstore chains, offering pharmaceuticals, daily necessities, cosmetics and related products, with a focus on domestic retail and pharmacy services. The group is expanding its footprint and scale in Japan’s drugstore sector through strategic integrations, including the recent business integration with WELCIA Holdings.

Average Trading Volume: 2,010,674

Technical Sentiment Signal: Buy

Current Market Cap: Yen1292.8B

For detailed information about 3391 stock, go to TipRanks’ Stock Analysis page.